Charles River Laboratories CRL Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Charles River Laboratories’s reported figures.
Plus components not separately reported this period.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's total debt?
- Charles River Laboratories (CRL) reported total debt of $3.07B in Q1 2026.
- How has Charles River Laboratories's total debt changed year-over-year?
- Charles River Laboratories's total debt increased by 1.9% year-over-year, from $3.02B to $3.07B.
- What is the long-term trend for Charles River Laboratories's total debt?
- Over 5 years (2020 to 2025), Charles River Laboratories's total debt has grown at a 4.0% compound annual growth rate (CAGR), from $2.19B to $2.66B.
- What does total debt mean?
- The total amount of money a company owes to banks, bondholders, and lessors.
- How do you interpret total debt?
- An increase suggests higher financial leverage and potentially increased interest expense, while a decrease indicates deleveraging or debt repayment. High levels relative to earnings may signal increased financial risk, whereas lower levels suggest a stronger balance sheet and greater financial flexibility.
- How does total debt compare across companies?
- Peers in the life sciences and contract research organization sectors typically maintain debt levels aligned with their acquisition strategies and capital expenditure cycles, often benchmarked against debt-to-EBITDA ratios.